HealthTechFundingNewsabout 4 hours ago
Houdini Bio raises £1.5M to fix gene therapy flaw
4 min read
Houdini Bio raised £1.5 million in grants and pre-seed funding led by SCVC. The startup's software redesigns therapeutic DNA to evade the HUSH protein complex, which causes gene therapies to lose effectiveness. The discovery came from CEO Jonathan Cohen-Gold's Cambridge PhD research.
Level
Hype check
Tap to vote and see what everyone thinks.
